BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen R, Cohen JF, Chalumeau M, Levy C. Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries. Expert Review of Vaccines 2017;16:625-40. [DOI: 10.1080/14760584.2017.1320221] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Diallo K, Feteh VF, Ibe L, Antonio M, Caugant DA, du Plessis M, Deghmane AE, Feavers IM, Fernandez K, Fox LM, Rodrigues CMC, Ronveaux O, Taha MK, Wang X, Brueggemann AB, Maiden MCJ, Harrison OB. Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review. EBioMedicine 2021;65:103274. [PMID: 33721818 DOI: 10.1016/j.ebiom.2021.103274] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Principi N, Esposito S. Development of pneumococcal vaccines over the last 10 years. Expert Opinion on Biological Therapy 2017;18:7-17. [DOI: 10.1080/14712598.2018.1384462] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, Madhi F, Hees L, Craiu I, Gras Le Guen C, Launay E, Zenkhri F, Lorrot M, Gillet Y, Béchet S, Hau I, Martinot A, Varon E, Angoulvant F, Cohen R. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children. JAMA Pediatr 2019;173:362-70. [PMID: 30715140 DOI: 10.1001/jamapediatrics.2018.5273] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
4 Zhou Z, Gilca R, Deceuninck G, Boucher F, De Wals P. Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec. Can J Public Health 2020;111:1041-8. [PMID: 32529553 DOI: 10.17269/s41997-020-00329-y] [Reference Citation Analysis]
5 Baqui AH, Koffi AK, McCollum ED, Roy AD, Chowdhury NH, Rafiqullah I, Ahmed ZB, Mahmud A, Begum N, Ahmed S, Khanam R, Harrison M, Simmons N, Hossen S, Islam M, Quaiyum A, Checkley W, Santosham M, Moulton LH, Saha SK; Projahnmo Study Group in Bangladesh. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies. Vaccine 2021;39:5794-801. [PMID: 34465471 DOI: 10.1016/j.vaccine.2021.08.068] [Reference Citation Analysis]
6 Edmondson-Jones M, Dibbern T, Hultberg M, Anell B, Medin E, Feng Y, Talarico C. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions. Hum Vaccin Immunother 2021;17:517-26. [PMID: 32574101 DOI: 10.1080/21645515.2020.1775455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett 2021;:1-32. [PMID: 34602924 DOI: 10.1007/s10311-021-01274-z] [Reference Citation Analysis]
8 Britton KJ, Pickering JL, Pomat WS, de Gier C, Nation ML, Pell CL, Granland CM, Solomon V, Ford RL, Greenhill A, Hinds J, Moore HC, Richmond PC, Blyth CC, Lehmann D, Satzke C, Kirkham LS; 10v13vPCV trial team. Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants. Vaccine 2021;39:5401-9. [PMID: 34384633 DOI: 10.1016/j.vaccine.2021.07.085] [Reference Citation Analysis]
9 Savrasova L, Krumina A, Cupeca H, Zeltina I, Villerusha A, Grope I, Viksna L, Dimina E, Balasegaram S. Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012-2018. Front Pediatr 2021;9:532489. [PMID: 34692599 DOI: 10.3389/fped.2021.532489] [Reference Citation Analysis]
10 Marra LP, Sartori AL, Martinez-silveira MS, Toscano CM, Andrade AL. Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review. Value in Health 2022. [DOI: 10.1016/j.jval.2021.12.012] [Reference Citation Analysis]
11 Lorton F, Chalumeau M, Martinot A, Assathiany R, Roué JM, Bourgoin P, Chantreuil J, Boussicault G, Gaillot T, Saulnier JP, Caillon J, Levy C, Cohen R, Gras-Le Guen C, Launay E. Epidemiology of Community-Onset Severe Bacterial Infections in Children and Its Evolution: A Population-Based Study in France. Pediatr Crit Care Med 2020;21:e325-32. [PMID: 32224829 DOI: 10.1097/PCC.0000000000002300] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cannon K, Elder C, Young M, Scott DA, Scully IL, Baugher G, Peng Y, Jansen KU, Gruber WC, Watson W. A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine 2021;39:7494-502. [PMID: 34839993 DOI: 10.1016/j.vaccine.2021.10.032] [Reference Citation Analysis]
13 Levy C, Cohen R. Tackling childhood pneumonia in Africa: a dream that becomes reality. Lancet Glob Health 2019;7:e288-9. [PMID: 30784621 DOI: 10.1016/S2214-109X(18)30532-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Boelsen LK, Dunne EM, Gould KA, Ratu FT, Vidal JE, Russell FM, Mulholland EK, Hinds J, Satzke C. The Challenges of Using Oropharyngeal Samples To Measure Pneumococcal Carriage in Adults. mSphere 2020;5:e00478-20. [PMID: 32727860 DOI: 10.1128/mSphere.00478-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zohra T, Numan M, Ikram A, Salman M, Khan T, Din M, Salman M, Farooq A, Amir A, Ali M. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens. Microorganisms 2021;9:954. [PMID: 33946643 DOI: 10.3390/microorganisms9050954] [Reference Citation Analysis]
16 Dudognon D, Levy C, Chalumeau M, Biscardi S, Dommergues MA, Dubos F, Levieux K, Aurel M, Minodier P, Zenkhri F, Mezgueldi E, Craiu I, Morin L, Béchet S, Varon E, Cohen R, Cohen JF; Pneumonia Study Group. Diagnostic Accuracy of Routinely Available Biomarkers to Predict Bacteremia in Children With Community-Acquired Pneumonia: A Secondary Analysis of the GPIP/ACTIV Pneumonia Study in France, 2009-2018. Front Pediatr 2021;9:684628. [PMID: 34746044 DOI: 10.3389/fped.2021.684628] [Reference Citation Analysis]
17 Silva-Costa C, Brito MJ, Aguiar SI, Lopes JP, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections., Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012-2015). Sci Rep 2019;9:6. [PMID: 30626918 DOI: 10.1038/s41598-018-36799-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Hubert-Dibon G, Danjou L, Feildel-Fournial C, Vrignaud B, Masson D, Launay E, Gras-Le Guen C. Procalcitonin and C-reactive protein may help to detect invasive bacterial infections in children who have fever without source. Acta Paediatr 2018;107:1262-9. [PMID: 29385638 DOI: 10.1111/apa.14248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, Saleem Z, Sneddon J, Hoxha I, Islam S, Mwita J, do Nascimento RCRM, Dias Godói IP, Niba LL, Amu AA, Acolatse J, Incoom R, Sefah IA, Opanga S, Kurdi A, Chikowe I, Khuluza F, Kibuule D, Ogunleye OO, Olalekan A, Markovic-Pekovic V, Meyer JC, Alfadl A, Phuong TNT, Kalungia AC, Campbell S, Pisana A, Wale J, Seaton RA. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel) 2021;11:528. [PMID: 34200116 DOI: 10.3390/life11060528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Shan W, Shi T, Zhang X, Xue J, Wang Y, Yu J, Huang Y, Lin S, Zhao G, Tian J, Zhang T. Hospitalization Rate and Population-based Incidence of Hospitalization for Community-acquired Pneumonia Among Children in Suzhou, China. Pediatric Infectious Disease Journal 2018;37:1242-7. [DOI: 10.1097/inf.0000000000002016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
22 Levy C, Varon E, Ouldali N, Béchet S, Bonacorsi S, Cohen R. Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation. Clinical Infectious Diseases 2019. [DOI: 10.1093/cid/ciz221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
23 Binks MJ, Beissbarth J, Oguoma VM, Pizzutto SJ, Leach AJ, Smith-Vaughan HC, McHugh L, Andrews RM, Webby R, Morris PS, Chang AB. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study. Lancet Child Adolesc Health 2020;4:425-34. [PMID: 32450122 DOI: 10.1016/S2352-4642(20)30090-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Izurieta P, Scherbakov M, Nieto Guevara J, Vetter V, Soumahoro L. Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Hum Vaccin Immunother 2022;:1-18. [PMID: 35020530 DOI: 10.1080/21645515.2021.2013693] [Reference Citation Analysis]
25 Ouldali N, Varon E, Levy C, Angoulvant F, Georges S, Ploy MC, Kempf M, Cremniter J, Cohen R, Bruhl DL, Danis K. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. Lancet Infect Dis 2021;21:137-47. [PMID: 32702302 DOI: 10.1016/S1473-3099(20)30165-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
26 Jansen KU, Knirsch C, Anderson AS. The role of vaccines in preventing bacterial antimicrobial resistance. Nat Med 2018;24:10-9. [DOI: 10.1038/nm.4465] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 24.3] [Reference Citation Analysis]
27 de-Miguel-Díez J, López-de-Andrés A, Hernández-Barrera V, de-Miguel-Yanes JM, Carabantes-Alarcón D, Ji Z, Zamorano-Leon JJ, Jiménez-García R. Sex-differences in incidence of hospitalizations and in hospital mortality of community-acquired pneumonia among children in Spain: a population-based study. Eur J Pediatr 2022. [PMID: 35469030 DOI: 10.1007/s00431-022-04478-9] [Reference Citation Analysis]
28 Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines 2021. [PMID: 34882050 DOI: 10.1080/14760584.2022.2012455] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Fathima P, Gidding HF, McIntyre PB, Snelling TL, McCallum L, de Klerk N, Blyth CC, Liu B, Moore HC. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study. Lancet Child Adolesc Health 2019;3:713-24. [PMID: 31439496 DOI: 10.1016/S2352-4642(19)30249-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
30 van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY. Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine. Vaccines (Basel) 2018;6:E82. [PMID: 30544898 DOI: 10.3390/vaccines6040082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Essink B, Peterson J, Yacisin K, Lal H, Mirza S, Xu X, Scully IL, Scott DA, Gruber WC, Jansen KU, Watson W. A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age. Hum Vaccin Immunother 2021;17:2691-9. [PMID: 33661716 DOI: 10.1080/21645515.2021.1890511] [Reference Citation Analysis]
32 Meder KN, Jayasinghe S, Beard F, Dey A, Kirk M, Cook H, Strachan J, Sintchenko V, Smith H, Giele C, Howden B, Krause V, Mcintyre P. Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians. Clin Infect Dis 2020;70:2607-15. [PMID: 31388670 DOI: 10.1093/cid/ciz731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
33 Murdoch DR, Howie SRC. The global burden of lower respiratory infections: making progress, but we need to do better. The Lancet Infectious Diseases 2018;18:1162-3. [DOI: 10.1016/s1473-3099(18)30407-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
34 Hurley D, Griffin C, Young M, Scott DA, Pride MW, Scully IL, Ginis J, Severs J, Jansen KU, Gruber WC, Watson W. Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age. Clin Infect Dis 2021;73:e1489-97. [PMID: 32716500 DOI: 10.1093/cid/ciaa1045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
35 Lecrenier N, Marijam A, Olbrecht J, Soumahoro L, Nieto Guevara J, Mungall B. Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine ( Synflorix ) in children. Expert Review of Vaccines 2020;19:247-65. [DOI: 10.1080/14760584.2020.1738226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother 2018;14:2142-9. [PMID: 29787323 DOI: 10.1080/21645515.2018.1476814] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
37 Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Review of Vaccines 2018;17:479-93. [DOI: 10.1080/14760584.2018.1413354] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
38 Boelsen LK, Dunne EM, Mika M, Eggers S, Nguyen CD, Ratu FT, Russell FM, Mulholland EK, Hilty M, Satzke C. The association between pneumococcal vaccination, ethnicity, and the nasopharyngeal microbiota of children in Fiji. Microbiome 2019;7:106. [PMID: 31311598 DOI: 10.1186/s40168-019-0716-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
39 Levy C, Varon E, Ouldali N, Wollner A, Thollot F, Corrard F, Werner A, Béchet S, Bonacorsi S, Cohen R. Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine. PLoS One 2019;14:e0211712. [PMID: 30707730 DOI: 10.1371/journal.pone.0211712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]